Identified the role of myeloma-specific inflammatory mesenchymal stromal cells in tumor survival and immune modulation; interferon-responsive effector T cell and CD8+ stem cell memory T-cell populations are potential sources of stromal cell–activating cytokines; successful antitumor induction therapy is unable to revert bone marrow inflammation. The gene discussed is CD8A; the disease is neoplasm.